Chitosans as absorption enhancers of poorly absorbable drugs. 3: Influence of mucus on absorption enhancement.

Chitosans are potent nontoxic absorption enhancers after nasal administration but their effects on the intestinal epithelium in vivo has not been studied in detail. In this study, the effects of chitosans with varying molecular weights and degrees of acetylation on the absorption of a poorly absorbed model drug (atenolol) were studied in intestinal epithelial cell layers with or without a mucus layer and in an in situ perfusion model of rat ileum. The effects of the chitosans on epithelial morphology and release of lactate dehydrogenase (LDH) into the perfusate were investigated in the in situ model. The chitosans had pronounced effects on the permeability of mucus-free Caco-2 layers and enhanced the permeation of atenolol 10- to 15-fold, with different absorption kinetics for different chitosans, in accordance with previous results. In contrast, enhancement of atenolol absorption through rat ileum was modest. LDH release from the tissues perfused with chitosans did not increase, indicating that the chitosans were used at nontoxic concentrations. Morphological examination of the perfused ileal tissues revealed more mucus discharge from the tissues exposed to chitosans than from controls, which suggested that the discharged mucus may inhibit the binding of chitosan to the epithelial surface and hence decrease the absorption-enhancing effect. This hypothesis was supported by studies with intestinal epithelial HT29-H goblet cells covered with a mucus layer. The binding of chitosan to the epithelial cell surface and subsequent absorption-enhancing effects were significantly reduced in mucus-covered HT29-H cultures. When the mucus layer was removed prior to the addition of chitosan, the cell surface binding and absorption-enhancing effects of the chitosans were increased. We conclude that the modest absorption-enhancing effects of unformulated chitosan solutions in the perfused rat ileum are a result of the mucus barrier in this tissue. This effect may be overcome by increasing the local concentrations of both chitosan and drug, i.e,. through formulation of the chitosan into a particulate dosage form.

[1]  T. Kararli Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals , 1995, Biopharmaceutics & drug disposition.

[2]  D. Louvard,et al.  Absorptive and mucus-secreting subclones isolated from a multipotent intestinal cell line (HT-29) provide new models for cell polarity and terminal differentiation , 1987, The Journal of cell biology.

[3]  P. Artursson,et al.  Co-cultures of human intestinal goblet (HT29-H) and absorptive (Caco-2) cells for studies of drug and peptide absorption , 1995 .

[4]  O. Smidsrod,et al.  Compositional heterogeneity of heterogeneously deacetylated chitosans , 1996 .

[5]  A. Macadam The effect of gastro-intestinal mucus on drug absorption , 1993 .

[6]  W. Higuchi,et al.  Quantitative mechanistic studies in simultaneous fluid flow and intestinal absorption using steroids as model solutes , 1980 .

[7]  R. Morris,et al.  Improved High‐Performance Liquid Chromatography Assay for Atenolol in Plasma and Urine Using Fluorescence Detection , 1991, Therapeutic drug monitoring.

[8]  O. Smidsrod,et al.  Solution properties of chitosans: conformation and chain stiffness of chitosans with different degrees of N-acetylation , 1993 .

[9]  J. Grove,et al.  Interaction of LS174T human colon cancer cell mucins with Entamoeba histolytica: an in vitro model for colonic disease. , 1996, Gastroenterology.

[10]  N. Houdret,et al.  Strong ionic interactions between mucins and two basic proteins, mucus proteinase inhibitor and lysozyme, in human bronchial secretions. , 1992, The International journal of biochemistry.

[11]  W. Higuchi,et al.  Advancing quantitative and mechanistic approaches in interfacing gastrointestinal drug absorption studies in animals and humans , 1983 .

[12]  P. Artursson,et al.  Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. , 1991, Biochemical and biophysical research communications.

[13]  O. Smidsrod,et al.  Water-solubility of partially N-acetylated chitosans as a function of pH: effect of chemical composition and depolymerisation , 1994 .

[14]  S. Davis,et al.  Sedimentation analysis of potential interactions between mucins and a putative bioadhesive polymer , 1994 .

[15]  P. Artursson,et al.  Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. , 1990, Journal of pharmaceutical sciences.

[16]  A. Quaroni,et al.  Development of intestinal cell culture models for drug transport and metabolism studies , 1996 .

[17]  P. Artursson Cell cultures as models for drug absorption across the intestinal mucosa. , 1991, Critical reviews in therapeutic drug carrier systems.

[18]  O. Smidsrod,et al.  Degradation of fully water-soluble, partially N-acetylated chitosans with lysozyme , 1994 .

[19]  A. Servin,et al.  Differentiation-associated antimicrobial functions in human colon adenocarcinoma cell lines. , 1996, Experimental cell research.

[20]  P. Artursson,et al.  Diffusion of drugs in native and purified gastrointestinal mucus. , 1997, Journal of pharmaceutical sciences.

[21]  G. Amidon,et al.  Carrier mediated transport of amino acids, small peptides, and their drug analogs , 1987 .

[22]  J. M. Creeth,et al.  Some non-mucin components of mucus and their possible biological roles. , 1984, Ciba Foundation symposium.